The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Short Interest Up 315.0% in July

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) was the recipient of a significant growth in short interest during the month of July. As of July 31st, there was short interest totalling 8,300 shares, a growth of 315.0% from the July 15th total of 2,000 shares. Based on an average daily volume of 21,200 shares, the short-interest ratio is presently 0.4 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Stock Performance

NASDAQ CGABL traded down $0.18 during trading hours on Monday, hitting $18.43. 7,555 shares of the company traded hands, compared to its average volume of 21,128. The business’s 50-day moving average is $18.36 and its 200-day moving average is $18.89. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a twelve month low of $15.60 and a twelve month high of $20.75.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Thursday, August 1st will be given a dividend of $0.2891 per share. The ex-dividend date of this dividend is Thursday, August 1st. This represents a $1.16 annualized dividend and a yield of 6.27%.

About Carlyle Group Inc. 4.625% Subordinated Notes due 2061

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.